Back

Treatment-adjusted detection and outcome risk for familial hypercholesterolaemia: dual external validation in 4,028 genetically confirmed cases across specialist and UKbiobank settings

30 August 2026 (09:05 - 09:15)
Organised by: Logo
Congress Presentation Part of: Novel markers to prevent cardiovascular risk Scores ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Nader Genedy

University Hospital for Wales, Cardiff (United Kingdom of Great Britain & Northern Ireland)

5 More presentations in this session

Presentation thumbnail
Prevalence of clinically actionable hsCRP and implications for statin eligibility and residual ASCVD risk in the United States
Doctor N. Chiu (Boston, US)
Abstract Slides
Presentation thumbnail
Gene-exposure interactions regulate cytokine-mediated chronic inflammation and cardiac remodeling
Doctor M. Coriano' (London, GB)
Abstract Slides
Presentation thumbnail
Longitudinal hsCRP assessment in routine care refines residual inflammatory risk estimates
Professor D. Wolf (Freiburg, DE)
Abstract Slides
Presentation thumbnail
Proposition of reference tables for a novel hs-cTnT assay to define “normal” considering relevant determinants in the general population
Doctor J. Lehmacher (Hamburg, DE) Professor R. Twerenbold (Hamburg, DE)
Abstract Slides
Presentation thumbnail
Prognostic utility of a next-generation high-sensitivity cardiac troponin T assay compared to an established high-sensitivity cardiac troponin I assay in the general population
Professor R. Twerenbold (Hamburg, DE)
Abstract Slides

Access the full session

Session thumbnail
Novel markers to prevent cardiovascular risk
Video

The Event

Event poster

ESC Congress 2026

30 August 2026 09:05 CET
You may be interested in
thumbnail
Congress Presentation
Predictors of cardiovascular disease in a familial hypercholesterolemia unit
13 April 2023
thumbnail
Congress Presentation
Validation of the familial hypercholesterolemia diagnosis in the Danish National Patient Registry and the Danish familial hypercholesterolemia registry
29 August 2025
thumbnail
Congress Presentation
RNA interference targeting apolipoprotein C-III with ARO-APOC3 in healthy volunteers mimics lipid and lipoprotein findings seen in subjects with inherited apolipoprotein C-III deficiency
31 August 2020
thumbnail
Congress Presentation
Sex-specific drug-target Mendelian randomisation on the effects of lipid-modifying targets on cardiovascular disease
4 April 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources